Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding

References

1. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk H-D et al. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol 2003; 77:8418–8425 [View Article][PubMed]
   [Google Scholar]
2. Oh DY, Barr IG, Mosse JA, Laurie KL. Mdck-Siat1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells; 2008; 462189–2194
3. Lin YP, Gregory V, Collins P, Kloess J, Wharton S et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J Virol 2010; 84:6769–6781 [View Article][PubMed]
   [Google Scholar]
4. Zhu X, McBride R, Nycholat CM, Yu W, Paulson JC et al. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J Virol 2012; 86:13371–13383 [View Article][PubMed]
   [Google Scholar]
5. Xue KS, Hooper KA, Ollodart AR, Dingens AS, Bloom JD et al. Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture. eLife 2016; 5:1–15 [View Article]
   [Google Scholar]
6. Xue KS, Greninger AL, Pérez-Osorio A, Bloom JD. Cooperating H3N2 influenza virus variants are not detectable in primary clinical samples. mSphere 2018; 3:e00552-17 [View Article][PubMed]
   [Google Scholar]
7. Mohr PG, Deng YM, McKimm-Breschkin JL. The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding. Virol J 2015; 12:67 [View Article][PubMed]
   [Google Scholar]
8. Tamura D, Nguyen HT, Sleeman K, Levine M, Mishin VP et al. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrob Agents Chemother 2013; 57:6141–6146 [View Article][PubMed]
   [Google Scholar]
9. Mögling R, Richard MJ, Vliet Svander, Beek Rvan, Schrauwen EJA et al. Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site. J Gen Virol 2017; 98:1274–1281 [View Article][PubMed]
   [Google Scholar]
10. Chambers BS, Li Y, Hodinka RL, Hensley SE. Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol 2014; 88:10986–10989 [View Article][PubMed]
    [Google Scholar]
11. Skowronski DM, Sabaiduc S, Chambers C, Eshaghi A, Gubbay JB et al. Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. Eurosurveillance 2016; 21:1–7 [View Article]
    [Google Scholar]
12. Lin Y, Wharton SA, Whittaker L, Dai M, Ermetal B et al. The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells. Influenza Other Respi Viruses 2017; 11:263–274 [View Article]
    [Google Scholar]
13. Lin YP, Xiong X, Wharton SA, Martin SR, Coombs PJ et al. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci USA 2012; 109:21474–21479 [View Article][PubMed]
    [Google Scholar]
14. Medeiros R, Escriou N, Naffakh N, Manuguerra JC, van der Werf S et al. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 2001; 289:74–85 [View Article][PubMed]
    [Google Scholar]
15. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010; 328:1272–1275 [View Article][PubMed]
    [Google Scholar]
16. Byrd-Leotis L, Cummings RD, Steinhauer DA. The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase. Int J Mol Sci 2017; 18:1541 [View Article]
    [Google Scholar]
17. Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA et al. Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 1998; 244:315–321 [View Article][PubMed]
    [Google Scholar]
18. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV et al. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 2000; 74:6015–6020 [View Article][PubMed]
    [Google Scholar]
19. Park S, Il Kim J, Lee I, Bae JY, Yoo K et al. Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses. Sci Rep 2017; 7:10928 [View Article][PubMed]
    [Google Scholar]
20. Wagner R, Matrosovich M, Klenk H-D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002; 12:159–166 [View Article][PubMed]
    [Google Scholar]
21. Takada K, Kawakami C, Fan S, Chiba S, Zhong G et al. A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses. Nat Microbiol 2019; 4:1268–1273 [View Article][PubMed]
    [Google Scholar]
22. Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 2005; 23:2943–2952 [View Article][PubMed]
    [Google Scholar]
23. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and swine origin human influenza A viruses. J Virol 2009; 83:10309–10313 [View Article][PubMed]
    [Google Scholar]